ENVICANA Canadian Trademark Information
Human pharmaceutical preparations for the treatment of metabolic, oncological, and immunological diseases Human pharmaceuticals for the prevention or treatment of auto-immune diseases, cardiovascular diseases, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases; pharmaceutical preparations for the prevention or treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; pharmaceutical preparations for the prevention or treatment of neurological diseases, namely Alzheimer's, Huntington's disease, and cerebral palsy; pharmaceutical preparations for the prevention or treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; anti-viral medications; anti-inflammatory medications; anti-pain medications; and anti-infective medications
Perfect for these industries
Words that describe this mark
human pharmaceutical preparations treatment metabolic oncological immunological diseases human pharmaceuticals prevention treatment autoimmune diseases cardiovascular diseases gastrointestinal diseases oncologic diseases ophthalmic diseases respiratory diseases pharmaceutical preparations prevention treatment metabolic diseases
Abandonment Notice!
On Tuesday, January 6, 2015,
status on the ENVICANA
trademark changed to Interruption of proceeding.
Apply Now for this name starting at $449!
CAUTION: Although Canada registration for this particular filing is inactive,
the mark may still enjoy common law rights, or may have been applied for again in a separate application.
Further research may be warranted to determine where this mark is truly abandoned in commerce.
On Tuesday, November 13, 2012, a canadian trademark registration was filed for
ENVICANA by Johnson & Johnson *********, **********, ***** ****.
The Canadian IP office has given the trademark application number of
1602116.
The current status of this trademark filing is Interruption of proceeding.
The correspondent listed for
ENVICANA is
GOWLING WLG (CANADA) LLP of *********, **********, ***** ****
The ENVICANA
trademark is filed in the description of
Human pharmaceutical preparations for the treatment of metabolic, oncological, and immunological diseases
,
Human pharmaceuticals for the prevention or treatment of auto-immune diseases, cardiovascular diseases, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases; pharmaceutical preparations for the prevention or treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; pharmaceutical preparations for the prevention or treatment of neurological diseases, namely Alzheimer's, Huntington's disease, and cerebral palsy; pharmaceutical preparations for the prevention or treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; anti-viral medications; anti-inflammatory medications; anti-pain medications; and anti-infective medications
.
100% Satisfaction Guarantee
protect your valuable brand now.
Classification Information
Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks.
Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms!
You can
register your trademark in 180+ countries
in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records.
Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.